Analgesia Additive Interaction between Tadalafil and Morphine in Experimental Animal Model.
暂无分享,去创建一个
Mohammed M Mehanna | M. Mehanna | S. Domiati | Hania Nakkash Chmaisse | A. El Mallah | Souraya Domiati
[1] J. Bidlack,et al. Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration , 2020, Psychopharmacology.
[2] Jun-Xu Li. Combining opioids and non-opioids for pain management: Current status , 2019, Neuropharmacology.
[3] S. Negus,et al. Core Outcome Measures in Preclinical Assessment of Candidate Analgesics , 2019, Pharmacological Reviews.
[4] M. Mehanna,et al. Antinociceptive effect of tadalafil in various pain models: Involvement of opioid receptors and nitric oxide cyclic GMP pathway , 2018, Toxicology and applied pharmacology.
[5] A. Moreira,et al. Potential anti-inflammatory effect of LQFM-021 in carrageenan-induced inflammation: The role of nitric oxide. , 2017, Nitric oxide : biology and chemistry.
[6] A. Masi,et al. Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation , 2016, Neuropharmacology.
[7] G. Sadan,et al. Antinociceptive Effect of Vardenafil on Carrageenan-Induced Hyperalgesia in Rat: involvement of Nitric Oxide/Cyclic Guanosine Monophosphate/Calcium Channels Pathway , 2015, Iranian journal of pharmaceutical research : IJPR.
[8] C. Upasani,et al. Involvement of NO–cGMP pathway in anti-hyperalgesic effect of PDE5 inhibitor tadalafil in experimental hyperalgesia , 2015, Inflammopharmacology.
[9] K. Hassanzadeh,et al. Simvastatin prevents morphine antinociceptive tolerance and withdrawal symptoms in rats. , 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.
[10] L. Lião,et al. Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021). , 2015, Nitric oxide : biology and chemistry.
[11] H. Miranda,et al. Isobolographic analysis of the opioid-opioid interactions in a tonic and a phasic mouse model of induced nociceptive pain , 2014, Journal of Biomedical Science.
[12] J. Sawynok,et al. Contributions of peripheral, spinal, and supraspinal actions to analgesia. , 2014, European journal of pharmacology.
[13] G. Pasternak. Opiate pharmacology and relief of pain. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Jaykaran Charan,et al. How to calculate sample size in animal studies? , 2013, Journal of pharmacology & pharmacotherapeutics.
[15] A. Ceylan,et al. The synergistic antinociceptive interactions of morphine and dexmedetomidine in rats with nerve-ligation injury. , 2013, Hippokratia.
[16] S. Fleming,et al. Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease , 2013, Journal of visualized experiments : JoVE.
[17] R. Tallarida,et al. Quantitative methods for assessing drug synergism. , 2011, Genes & cancer.
[18] FQ Cunha,et al. Tadalafil analgesia in experimental arthritis involves suppression of intra‐articular TNF release , 2011, British journal of pharmacology.
[19] A. Altun,et al. The nitric oxide-cGMP signaling pathway plays a significant role in tolerance to the analgesic effect of morphine. , 2011, Canadian journal of physiology and pharmacology.
[20] H. Loh,et al. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene , 2010, Journal of Biomedical Science.
[21] David Julius,et al. Cellular and Molecular Mechanisms of Pain , 2009, Cell.
[22] C. Carson. Tadalafil for the treatment of erectile dysfunction. , 2008, Current urology reports.
[23] W. Kim,et al. Additive Antinociception between Intrathecal Sildenafil and Morphine in the Rat Formalin Test , 2008, Journal of Korean medical science.
[24] Gary M. Pollack,et al. Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective , 2008, The AAPS Journal.
[25] P. Flood,et al. The Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia , 2008, Anesthesia and analgesia.
[26] J. N. Sharma,et al. Role of nitric oxide in inflammatory diseases , 2007, Inflammopharmacology.
[27] A. Malmberg,et al. Models of Nociception: Hot‐Plate, Tail‐Flick, and Formalin Tests in Rodents , 2007, Current protocols in neuroscience.
[28] H. Bae,et al. Synergistic antinociception between zaprinast and morphine in the spinal cord of rats on the formalin test , 2006, European journal of anaesthesiology.
[29] J. Corbin,et al. Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction , 2005, Expert opinion on drug metabolism & toxicology.
[30] V. Granados-Soto,et al. Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test. , 2005, European journal of pharmacology.
[31] A. Bella,et al. Tadalafil in the treatment of erectile dysfunction , 2003, Current urology reports.
[32] J. Choi,et al. Pharmacologic Interaction between Cannabinoid and either Clonidine or Neostigmine in the Rat Formalin Test , 2003, Anesthesiology.
[33] J. E. Torres-López,et al. Peripheral Antinociceptive Action of Morphine and the Synergistic Interaction with Lamotrigine , 2002, Anesthesiology.
[34] M. Hammarlund-Udenaes,et al. Aspects on tail-flick, hot-plate and electrical stimulation tests for morphine antinociception. , 1998, Pharmacology & toxicology.
[35] V. Granados-Soto,et al. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. , 1997, European journal of pharmacology.
[36] L. Merkel. Zaprinast: A cGMP-Selective Phosphodiesterase Inhibitor , 1993 .
[37] M. Fennessy,et al. Comparison of the dose‐response effects of morphine on brain amines, analgesia and activity in mice , 1972, British journal of pharmacology.
[38] Y. Yeh,et al. Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. , 2009, British journal of anaesthesia.